Evidence And Insights: Analysis On The Power Of Digital Trials

Clinical product development is undergoing rapid transformation. Technological revolutions are accelerating, with tablets reaching 10% market penetration in just five years, compared to 30 years for electricity. Post-COVID, remote data capture, virtual visits, and wearable sensors became standard in clinical trials. The rise of AI, machine learning, and automation, highlighted by the release of generative AI in 2023, is revolutionizing clinical research. Digital technologies like eCOA are projected to reach $4.7 billion by 2030, with AI and ML poised to transform areas like women's health, oncology, and rare diseases.

Medable, in partnership with academic institutions, has demonstrated the impact of these technologies, while regulatory bodies like the FDA and EMA are issuing new guidelines. To address the 10,000 remaining human diseases, we must accelerate the pace of research. Here’s how Medable and industry peers are driving this change.